Effect of autologous versus allogeneic blood transfusion on clinical and paraclinical outcomes in patients undergoing selective surgery
Phase 3
Recruiting
- Conditions
- Blood transfusion on clinical and paraclinical outcomes.Complications following infusion, transfusion and therapeutic injection
- Registration Number
- IRCT20120215009014N507
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Age 18 to 80 years
Indications for non-emergency chest and abdominal surgery
Hemoglobin above 11, hematocrit above 30, and platelets above 150,000 before surgery
Exclusion Criteria
Heart or lung disease or high blood pressure
Seizure registration
AIDS
Hepatitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin and hematocrit levels. Timepoint: 48 hours after blood transfusion. Method of measurement: By taking blood samples.;Average days of hospitalization. Timepoint: After surgery. Method of measurement: According to the medical record.
- Secondary Outcome Measures
Name Time Method Occurrence of hypersensitivity reactions. Timepoint: Immediately after blood transfusion and 24 hours later. Method of measurement: With clinical examination and investigation of blood inflammatory factors.